# Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/evidence-of-ntrk1-fusion-as-resistance-mechanism-to-egfr-tki-in-egfr-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hui Xia,Xingyang Xue,Huaxin Ding,Qiuxiang Ou,Xue Wu,Misako Nagasaka,Yang Shao,Xingsheng Hu,Sai‐Hong Ignatius Ou |
| Citations | 94 |
| DOI | 10.1016/j.cllc.2019.09.004 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2976640752 |
| PMID | 31761448 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Xingsheng Hu](https://scholariq.org/researchers/xingsheng-hu/)

## Paper journal

- [Clinical Lung Cancer](https://scholariq.org/journals/clinical-lung-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer, Stress, Anesthesia, and Immune Response](https://scholariq.org/topics/cancer-stress-anesthesia-and-immune-response/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.